Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110835639A reveals a dual-enzyme DKR process for high-purity (S)-tetrahydroisoquinoline derivatives, offering superior ee values and scalable manufacturing for pharmaceutical intermediates.
Patent CN110804062B details a high-yield synthesis of chiral lactone for biotin. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN104628584A reveals a mild synthesis route for dapoxetine. Achieve 99.9% purity with reduced toxicity and significant cost reduction in API manufacturing.
Patent CN110317849B reveals a high-yield enzymatic method for producing chiral tetrahydroisoquinoline intermediates, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN110835639B reveals a high-efficiency enzymatic route for producing chiral tetrahydroisoquinoline intermediates with superior stereoselectivity and scalable manufacturing potential.
Patent CN113214267B reveals a novel one-step crystallization method for eszopiclone, offering high purity and significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN104151249B details a high-purity chiral resolution method using camphorsulfonic acid, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN111004179B details a high-purity resolution method for 5'-methoxylaudanosine, offering superior yield and optical purity for neuromuscular blocker synthesis.
Patent CN113072480A reveals a scalable chemical resolution route for chiral (-)-5-azaspiro[2.4]heptane-7-alcohol, offering superior purity and cost efficiency for API manufacturing.
Patent CN1425019A discloses a novel enzymatic route for vitamin D precursors, offering cost reduction in pharmaceutical intermediates manufacturing through scalable crystallization.
Patent CN112301064A reveals a biocatalytic route for high-purity DV acid. This method simplifies purification and ensures reliable agrochemical intermediate supply.
Patent CN1950326A details a high-yield optical resolution and recycling process for atomoxetine intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel Strecker reaction route for Clopidogrel bisulfate. High yield, scalable process for pharmaceutical intermediates manufacturing.
Novel asymmetric conversion method boosts yield to over 80 percent for L-2-aminobutyric acid, offering cost-effective pharma intermediate supply.
Patent CN1989093A details a scalable diastereomeric resolution method for spirobiindane derivatives, offering cost reduction and high purity for liquid crystal and polymer applications.
Novel synthesis of Aliskiren intermediate via etherification and enzymatic resolution. Reduces steps and cost for API manufacturing significantly.
Advanced preparation method for Pitavastatin Calcium offering high yield and simplified purification for reliable API supply chains and cost-effective manufacturing.
Novel pH-dependent resolution method for Isavuconazole Intermediate 4 offering high purity and reduced operational complexity for pharmaceutical supply chains globally.
Patent CN114573411B reveals a safer synthesis route for Palonosetron intermediates, eliminating n-hexane and improving purity for reliable pharmaceutical intermediates supplier partnerships.
Novel catenane resolving agent method ensures high ee values and scalable production for pharmaceutical intermediates.